GSK positive CHMP opinion recommending Jemperli plus chemotherapy to treat endometrial cancer
GSK positive CHMP opinion recommending Jemperli plus chemotherapy to treat endometrial cancer
Source: directorstalkinterviews.com
Page 2 - Virtual Plenary News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Virtual Plenary. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Virtual Plenary Today - Breaking & Trending Today
Novartis : Kisqali® reduced the risk of cancer recurrence while maintaining quality of life in patients diagnosed with early breast cancer -September 14, 2023 at 01:26 pm EDT
Breast Cancer. NCCN Guidelines. Published March 2023. Available at: https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf/ Accessed August 2023. European Society...
Source: marketscreener.com
Banco do Brasil S A : Financial Statements 2Q23
Consolidated financial statements. In the preparation of the consolidated financial statements, amounts resulting from transactions between consolidated companies, including the equity...
Source: marketscreener.com
Jemperli (dostarlimab-gxly) plus chemotherapy approved in the US as the first new frontline treatment option in decades for dMMR/MSI-H primary advanced or recurrent endometrial cancer
Jemperli is the only immuno-oncology treatment approved in the frontline setting for this patient population in combination with chemotherapy Patients with this type of endometrial cancer face...
Source: marketscreener.com
Jemperli (dostarlimab-gxly) plus chemotherapy approved in the US as the first new frontline treatment option in decades for dMMR/MSI-H primary advanced or recurrent endometrial cancer
31.07.2023 - GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Jemperli (dostarlimab-gxly) in combination with carboplatin and paclitaxel, followed by Jemperli as a single agent for the treatment of adult ...
Source: wallstreet-online.de